VYOME HOLDINGS, INC. Restructuring and Related Cost, Number of Positions Eliminated
VYOME HOLDINGS, INC. (HIND) reported Restructuring and Related Cost, Number of Positions Eliminated of 49 employee for the 1-month period ending 2019-04-30, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2021-03-12
- 2019-04-30: Restructuring and Related Cost, Number of Positions Eliminated 1 month 49.00 employee.
- 2019-04-02: Restructuring and Related Cost, Number of Positions Eliminated 49.00 employee.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated | Restructuring and Related Cost, Number of Positions Eliminated 1 month |
|---|---|---|
| 2019-04-30 | 49.00 employee 10-K · filed 2021-03-12 | |
| 2019-04-02 | 49.00 employee 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |